![Victor Tong](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 31/05/2026
Victor E.
Tong is currently Director at Levitasbio, Inc., Nalu Medical, Inc., Shenzhen GeneMDx Biotech Co., Ltd., Take2 Consulting LLC, Cellares Corp., Cirina, Inc., Watchmaker Genomics, Inc., and Hummingbird Bioscience, Inc. He is Independent Director at CG Oncology, Inc. since 2023 and Aardvark Therapeutics, Inc. since 2024.
He serves as Managing Director at Decheng Capital LLC (United States) since 2012 and Partner at Decheng Capital LLC since 2011.
Former roles include Chairman at ReadCoor, Inc., Director at SentreHEART, Inc., GeneWeave Biosciences, Inc., EpimAb Biotherapeutics, Inc., and Levitas, Inc., Principal at Incyte Corp.
and Hana Biosciences, Inc., Member at Morgan Stanley & Co. LLC in 2008, and Analyst at Bay City Capital LLC.
Education includes undergraduate studies at the University of California, Berkeley.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
CG ONCOLOGY, INC. -.--% | 04/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CG ONCOLOGY, INC. | Direttore/Membro del Consiglio | 01/07/2023 |
| AARDVARK THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/05/2024 |
Decheng Capital LLC
 Decheng Capital LLC Investment ManagersFinance Decheng Capital LLC invests in life sciences companies which have strong links to China. It targets companies operating in the fields of Health Technology, Health Services and Technology Service sector. It provides financing for incubation to later stage capital requirements and takes lead or co-lead position. It invests in both public and private companies | Investitore di Private Equity | 01/01/2011 |
Decheng Capital LLC (United States)
 Decheng Capital LLC (United States) Finance/Rental/LeasingFinance Part of Decheng Capital LLC, Decheng Capital LLC is a life sciences investment firm established in 2012, managing $2.1 billion in capital. The company is based in Menlo Park, CA. The firm specializes in providing capital and strategic support to early-stage life science companies with innovative technologies, as well as growth-stage healthcare companies with strong market presence. | Corporate Officer/Principal | 01/01/2012 |
Cirina, Inc.
 Cirina, Inc. Medical/Nursing ServicesHealth Services Operates medical laboratories | Direttore/Membro del Consiglio | - |
Watchmaker Genomics, Inc.
 Watchmaker Genomics, Inc. BiotechnologyHealth Technology Engages in designing, development and production of DNA and RNA modifying enzymes | Direttore/Membro del Consiglio | - |
Take2 Consulting LLC
 Take2 Consulting LLC Personnel ServicesCommercial Services Provides information technology staffing and services | Direttore/Membro del Consiglio | - |
Nalu Medical, Inc.
 Nalu Medical, Inc. Medical SpecialtiesHealth Technology Develops medical devices to manage intractable chronic pain | Direttore/Membro del Consiglio | - |
Hummingbird Bioscience | Direttore/Membro del Consiglio | - |
| ░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
| Società | Posizione | Fine |
|---|---|---|
| ░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░ ░░░░░ ░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 22 |
|---|---|
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
SentreHEART, Inc.
 SentreHEART, Inc. Medical SpecialtiesHealth Technology Develops catheter based solutions | Health Technology |
GeneWeave Biosciences, Inc.
 GeneWeave Biosciences, Inc. Medical/Nursing ServicesHealth Services Develops a platform for detecting infectious diseases | Health Services |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Hana Biosciences, Inc. /Old/
 Hana Biosciences, Inc. /Old/ Pharmaceuticals: OtherHealth Technology Acquires, develops, and commercializes innovative products for the treatment of important unmet medical needs in cancer and immunological diseases | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bay City Capital LLC
 Bay City Capital LLC Investment ManagersFinance Bay City Capital invests in public and private companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and later stage capital transactions. The firm makes co-investments. It acts as a lead investor and takes a seat on the board of directors. | Finance |
CG Oncology, Inc.
 CG Oncology, Inc. BiotechnologyHealth Technology Operates as a late-stage clinical biopharmaceutical company focused on developing and commercializing backbone bladder-sparing therapeutic | Health Technology |
Decheng Capital LLC
Decheng Capital LLC Investment ManagersFinance Decheng Capital LLC invests in life sciences companies which have strong links to China. It targets companies operating in the fields of Health Technology, Health Services and Technology Service sector. It provides financing for incubation to later stage capital requirements and takes lead or co-lead position. It invests in both public and private companies | Finance |
Nalu Medical, Inc.
Nalu Medical, Inc. Medical SpecialtiesHealth Technology Develops medical devices to manage intractable chronic pain | Health Technology |
Shenzhen GeneMDx Biotech Co., Ltd.
 Shenzhen GeneMDx Biotech Co., Ltd. BiotechnologyHealth Technology Manufactures biologique products | Health Technology |
ReadCoor, Inc.
 ReadCoor, Inc. Internet Software/ServicesTechnology Services Operates sequencing platform that develops fluorescence in-situ sequencing technology to provides cellular location and spatial image data | Technology Services |
EpimAb Biotherapeutics, Inc.
 EpimAb Biotherapeutics, Inc. MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
Levitas, Inc.
 Levitas, Inc. Packaged SoftwareTechnology Services Develops software applications for redefining cellular analytics | Technology Services |
Decheng Capital LLC (United States)
Decheng Capital LLC (United States) Finance/Rental/LeasingFinance Part of Decheng Capital LLC, Decheng Capital LLC is a life sciences investment firm established in 2012, managing $2.1 billion in capital. The company is based in Menlo Park, CA. The firm specializes in providing capital and strategic support to early-stage life science companies with innovative technologies, as well as growth-stage healthcare companies with strong market presence. | Finance |
Aardvark Therapeutics, Inc.
 Aardvark Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapeutics for obesity and metabolic diseases | Health Technology |
Take2 Consulting LLC
Take2 Consulting LLC Personnel ServicesCommercial Services Provides information technology staffing and services | Commercial Services |
Levitasbio, Inc.
 Levitasbio, Inc. Packaged SoftwareTechnology Services Develops magnetic levitation technology | Technology Services |
Cellares Corp.
 Cellares Corp. BiotechnologyHealth Technology Engages in developing and operating integrated technologies for cell therapy manufacturing | Health Technology |
Cirina, Inc.
Cirina, Inc. Medical/Nursing ServicesHealth Services Operates medical laboratories | Health Services |
Watchmaker Genomics, Inc.
Watchmaker Genomics, Inc. BiotechnologyHealth Technology Engages in designing, development and production of DNA and RNA modifying enzymes | Health Technology |
Hummingbird Bioscience | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
